| 标题 |
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Grande E; Arranz JÁ; De Santis M; Bamias A; Kikuchi E; et al 出版日期:2024/01/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)